Posts Tagged ‘medical’
-
Wednesday, July 7th, 2010 at 07:20 | Comments Off
Answers to Some of Your Burning Sunscreen QuestionsCategories: Wall Street Journal -
Saturday, July 3rd, 2010 at 00:49 | Comments Off
When it Comes to Defining a ‘Medical Cost,’ Devil’s in the DetailsCategories: Wall Street Journal, insurance -
Tuesday, May 11th, 2010 at 10:01 | Comments Off
Using a Remote to Turn Off the PainCategories: Wall Street Journal
Nearly a quarter of U.S. adults suffer from chronic pain that ranges from nagging aches to debilitating agony. A new therapy involving remote-controlled nerve stimulation is offering some relief. Dr. Christopher Winfree of Columbia University Medical Center explains.
Excerpt from: Using a Remote to Turn Off the Pain/a>
-
Friday, April 23rd, 2010 at 01:54 | Comments Off
Lowden’s Medical Barter Idea: Not So Nuts After All?Categories: Wall Street Journal
Nevada senatorial candidate Sue Lowden’s suggestion that lower health-care costs can be had by swapping chickens for treatment has been mocked rather mercilessly. The Republican, who is trying to unseat Sen. Majority Leader Harry Reid, recently confirmed that when she said consumers could “barter” to reduce their medical bills, yes, she really did mean “swapping goods and services,” not “bargain.” The Democrats have gleefully responded with a Web tool allowing people to email Lowden’s campaign with tailored requests to find ..read more
-
Tuesday, April 13th, 2010 at 11:08 | Comments Off
Is There a Competent Doctor in the House?Categories: Wall Street Journal
A program at the University of California San Diego known as PACE –- for Physician Assessment and Clinical Education — is being used by a growing number of hospitals and state medical boards to assess the competency of troubled doctors, according to an article in today’s WSJ special report on Innovations in Health Care.
The program is one of the few to tackle a thorny problem in health care: how to ensure that doctors remain competent to practice once they have ..read more
-
Friday, April 2nd, 2010 at 07:36 | Comments Off
Medicare Docs Guess at Paychecks Amid Reimbursement QuestionsCategories: Wall Street Journal
It’s no joke for doctors that today marks the day that Medicare’s 21% reimbursement pay cuts were to go into effect.
Congress left for its Easter recess without voting to delay the scheduled April 1 start of lower payments to docs. The agency that oversees Medicare has effectively delayed the cuts by deciding not to pay claims for the first 10 business days in April. When Congress returns, it’s still expected to adopt another law to delay the cuts for ..read more
-
Friday, March 26th, 2010 at 23:24 | Comments Off
Doctors Shift to Health Centers, Away from Private PracticeCategories: Wall Street Journal
More and more doctors are moving away from private practice and are instead becoming employees of hospitals and health systems, reports the NYT.
This trend could mean more coordinated and better care for patients, though without the personal touch that private practice offers. Patients are more likely to see the same doctor in private practice than they are in a health center setting.
For docs, receiving a salary from an employer could mean less worries about changes to the health-care system. They ..read more
-
Wednesday, March 17th, 2010 at 23:29 | Comments Off
Putting a Dollar Figure on a Doctor’s Worth to a HospitalCategories: Wall Street Journal
What’s a doctor worth to a hospital in terms of annual revenue? And what specialties average the most and the least in hospital revenue generation?
The answer to the first question averages about $1.54 million a year, based on 114 U.S. hospital responding to a survey by physician recruiters Merritt Hawkins. That’s up slightly from the $1.5 million a year per doc that hospitals averaged in revenue in 2007, the last time the recruiting outfit took the survey. (Revenue here ..read more
-
Wednesday, March 17th, 2010 at 02:14 | Comments Off
Merck and Portola: Finding a Blood Thinner’s Sweet SpotCategories: Wall Street Journal
“In evaluating an anticoagulant,” says heart researcher Michael Ezekowitz, “it’s all about getting the dose right.”
That’s the next big challenge for Merck and its partner Portola as they prepare to advance the closely held South San Francisco biotech’s drug betrixaban into a large-scale clinical trial in the burgeoning race to develop a replacement for the heart drug warfarin.
Ezekowitz, a cardiologist at Lankenau Institute for Medical Research, Wynnewood, Pa., told a packed auditorium at the annual science meeting of the American ..read more
-
Tuesday, March 16th, 2010 at 08:50 | Comments Off
Boston Scientific Faces $5 Million-a-Day Paperwork ProblemCategories: Wall Street Journal
Boston Scientific is back in the regulatory doghouse after the medical-device maker failed to report to the FDA changes in how it manufactures its line of implantable heart defibrillators
The company has recalled the devices and halted further shipments until it resolves the reporting issue with the FDA. The business accounts for 15% of its revenue, which totaled $8.19 billion in 2009. Sanford Bernstein analyst Derrick Sung, tells the WSJ’s Jonathan Rockoff the sales suspension will cost the company ..read more

